Skip to main content
Clinical Trials/NCT02295709
NCT02295709UnknownNot Applicable

Cervical Transforaminal Injection of Steroids Guided by Ultrasound

Shanghai Jiao Tong University Affiliated Sixth People's Hospital0 sites60 target enrollmentStarted: January 2014Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
60
Primary Endpoint
change of pain severity rated on a Visual Analog Scale (VAS)

Study Overview

Brief Summary

Cervical transforaminal epidural steroid injections (TFESI) are indicated in cervical radicular pain resistant to conservation therapy, by which steroids can be delivered into anterior epidural space surrounding target spinal nerve roots to help alleviate pain in the upper limb or neck. Cervical TFESI is traditionally commended to perform with guidance of fluoroscopy or CT. As fluoroscopy can not monitor the injection route whether it pass vessel or not, many serious neurological complications caused by inadvertent intra-arterial injection have been reported2. Here, the investigators will introduce a novel cervical TFESI guided by ultrasound, which incidence of inadvertent vessel injury or injection might be lower than those guided by fluoroscopy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • evidence of a cervical radiculopathy involving 1 spinal nerve of at least 1 month's duration refractory to medical treatment
  • symptoms of cervical pain radiating to the upper limb
  • and signs of altered sensations, ab- normal reflexes, or motor weakness caused by degenerative spondylosis and/or disk herniation as documented at CT or MR imaging and a current mean pain VAS score of six.
  • Exclusion criteria:
  • evidence of vertebral fracture, tumor, or infection of the cervical spine
  • treatment with cervical corticosteroid injections within the past 3 months
  • coagulopathy
  • allergy to iodinated contrast media.

Exclusion Criteria

  • Not provided

Arms & Interventions

USNR steroid injection

Experimental

the patient who are treated with steroid (dexamethasone) injection through selected cervical spinal nerve block approach guided by ultrasound and C arm.

Intervention: SNR steroid (dexamethasone) injection (Procedure)

USNR steroid injection

Experimental

the patient who are treated with steroid (dexamethasone) injection through selected cervical spinal nerve block approach guided by ultrasound and C arm.

Intervention: Dexamethasone (Drug)

USNR steroid injection

Experimental

the patient who are treated with steroid (dexamethasone) injection through selected cervical spinal nerve block approach guided by ultrasound and C arm.

Intervention: Ultrasound (Device)

USNR steroid injection

Experimental

the patient who are treated with steroid (dexamethasone) injection through selected cervical spinal nerve block approach guided by ultrasound and C arm.

Intervention: C arm (Radiation)

UCTF steroid injection

Experimental

the patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided by ultrasound and C arm.

Intervention: CTF steroid (dexamethasone) injection (Procedure)

UCTF steroid injection

Experimental

the patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided by ultrasound and C arm.

Intervention: Dexamethasone (Drug)

UCTF steroid injection

Experimental

the patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided by ultrasound and C arm.

Intervention: Ultrasound (Device)

UCTF steroid injection

Experimental

the patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided by ultrasound and C arm.

Intervention: C arm (Radiation)

XCTF steroid injection

Experimental

the patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided only by C arm.

Intervention: CTF steroid (dexamethasone) injection (Procedure)

XCTF steroid injection

Experimental

the patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided only by C arm.

Intervention: Dexamethasone (Drug)

XCTF steroid injection

Experimental

the patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided only by C arm.

Intervention: C arm (Radiation)

Outcomes

Primary Outcomes

change of pain severity rated on a Visual Analog Scale (VAS)

Time Frame: 1 day before, 1day after, 1week after and 4 weeks after the intervention

Secondary Outcomes

  • change of medication use rated on Medication Quantitative Scale (MQS)(1 day before, 1day after, 1week after and 4 weeks after the intervention)
  • change of neck actives rated on Neck Disability Index (NDI)(1 day before, 1day after, 1week after and 4 weeks after the intervention)

Investigators

Sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dongping Du

Pain Management Center

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Similar Trials